-
Peerwith partners with academic publisher, De Gruyter to develop collaborative peer-2-peer marketplace for authors
Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dating back to 1749.
-
£30m global cardiovascular challenge launched
British Heart Foundation to tackle the suffering and devastation caused by heart and circulatory diseases with historic research award London, UK, 25th August 2018 / Sciad Newswire / The British Heart Foundation (BHF) is today launching the Big Beat Challenge, a unique research funding award that will bring together world-leading researchers and innovators to identify and solve any…
-
ReViral announces US$55 million series B fundraising to advance RSV clinical studies
London, UK, 1st August 2018 / Sciad Newswire / ReViral, an antiviral drug discovery and development company, focused on diseases caused by the Respiratory Syncytial Virus (RSV), today announced the successful completion of a US$55 million Series B financing. The new funding will enable ReViral to progress its lead drug candidate (RV521), a highly potent and orally…
-
DOULIX launches new DNA assembly tool perfect for iGEM students
Venice, Italy, 25th July 2018 / Sciad Newswire / DOULIX ™, the synthetic biology toolbox to design, analyse and synthesise biological systems, today announced the launch of its new DNA assembly tool, the MoCLO wizard. The computer-aided wizard facilitates the design and assembly of synthetic DNA constructs by the user. It is a result of collaboration between Doulix and Dr Emmanuele Severi, University…
-
Domainex opens for business in Boston and San Diego
New business development team will support clients across the US Cambridge, UK, 19th July 2018 / Sciad Newswire / Domainex Ltd, Europe’s fastest growing drug discovery service company, is pleased to announce its expansion to the US with the appointment of a new business development team and the opening of East and West coast offices in Boston, MA…
-
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the company’s dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL).
-
Kicking cookbooks into the digital age
‘Spotify for cookbooks’ service launches kickstarter for founder subscribers New York, USA / London, UK, 10th July 2018 / Sciad Newswire / ckbk, a new service providing seamless digital access to the world’s best cookbooks, today announced the launch of its kickstarter campaign with exclusive early access, benefits and rewards for founder subscribers. ckbk offers unlimited online…
-
Five major UK Life Sciences Membership Associations team up to lobby parliament regarding Entrepreneurs Relief
Open Letter to the Chancellor of the Exchequer on Entrepreneurs’ Relief Oxford, UK, 25th June 2018 / Sciad Newswire / OBN, OneNucleus, BioNow, Medilink Midlands and MediWales, major not-for-profit life sciences membership organisations in the UK, which together represent around 2,000 active life sciences companies, have sent an open letter on Friday 22 June 2018, to the Chancellor of…
-
Darren Beckinsale joins The RSA Group as Consultant
London, UK, 25th June 2018 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced today that Darren Beckinsale has joined the firm as a Consultant. Darren will form part of the firm’s fast-growing Interims Practice. Darren has over 17 years’ experience in search, working almost exclusively in clinical healthcare and tech….
-
David Venables wins the Disruptor category of EY Entrepreneur Of The Year 2018, Scotland
Edinburgh, UK, 22nd June 2018 / Sciad Newswire / Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ category of Scotland’s EY Entrepreneur Of The Year 2018. David was nominated in the ‘Disruptor’ category, recognising entrepreneurs ‘with the vision and courage to challenge the status quo’ and…